iPhone | iPad
Android
Huawei
F1 leader returns to dominant form after his record run of 10 consecutive victories was ended in Singapore
KT APPDOWNLOAD
Covid-19: BioNTech, Pfizer say 3 vaccine doses neutralise Omicron variant
If needed, the two companies said they can deliver an Omicron-based vaccine in March 2022
Reuters
BioNTech and Pfizer said on Wednesday a three-shot course of their Covid-19 vaccine was shown to generate a neutralising effect against the new Omicron variant in a laboratory test.
In the first official statement from vaccine manufacturers on the likely efficacy of their shot against Omicron, BioNTech and Pfizer said in a joint statement that two vaccine doses resulted in significantly lower neutralising antibodies but that a third dose of their vaccine increased the neutralising antibodies by a factor of 25.
They added that, if needed, they can deliver an Omicron-based vaccine in March 2022.
ALSO READ:
More news from
Delayed a year due to China's measures to combat the COVID-19 pandemic, Asia's biggest sporting spectacle will be one of the country's most prestigious events in more than a decade
RTA and Hipa announce third edition of mobile photography competition
Indian-born bowler becomes first Kiwi spinner to claim six wickets in a one-day international
Luton earn first point through Morris penalty as Crystal Palace and Fulham play out goalless draw
The Dubai Ruler and Deputy Prime Minister sent similar cables of condolences to the Prime Minister of Italy, Giorgia Meloni
Abu Dhabi star underlines F2 dominance as battle for silver and bronze goes down to the wire
It is not immediately known how long the sailors were stranded in Yemen